Cryo-Cell International, Inc.
General ticker "CCEL" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $46.5M (TTM average)
Cryo-Cell International, Inc. does not follow the US Stock Market performance with the rate: -40.4%.
Estimated limits based on current volatility of 0.8%: low 3.26$, high 3.31$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-05-21, amount 0.15$ (Y18.29%)
- Total employees count: 86 (-2.3%) as of 2024
- Top business risk factors: Insufficient funding, Economic downturns and volatility, Regulatory and compliance, Political instability, ESG risks
- Current price 37.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-11-30 to 2026-11-30
- 2024-11-30 to 2025-11-30 estimated range: [5.46$, 10.26$]
- 2025-11-30 to 2026-11-30 estimated range: [5.28$, 10.06$]
Financial Metrics affecting the CCEL estimates:
- Positive: with PPE of 15.7 at the end of fiscal year the price was low
- Positive: 7.67 < Operating profit margin, % of 10.88
- Positive: 6.64 < Operating cash flow per share per price, % of 8.71
- Positive: Interest expense per share per price, % of 2.70 <= 3.28
- Negative: Investing cash flow per share per price, % of -7.07 <= -4.43
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.62
- Negative: Shareholder equity ratio, % of -20.43 <= 19.40
- Positive: Inventory ratio change, % of -0.02 <= 0
Short-term CCEL quotes
Long-term CCEL plot with estimates
Financial data
| YTD | 2023-11-30 | 2024-11-30 | 2025-11-30 |
|---|---|---|---|
| Operating Revenue | $31.34MM | $31.99MM | $31.57MM |
| Operating Expenses | $43.65MM | $28.51MM | $31.08MM |
| Operating Income | $-12.30MM | $3.48MM | $0.48MM |
| Non-Operating Income | $-1.06MM | $-0.68MM | $-2.82MM |
| Interest Expense | $1.24MM | $1.86MM | $2.07MM |
| R&D Expense | $1.17MM | $1.24MM | $0.38MM |
| Income(Loss) | $-13.36MM | $2.80MM | $-2.34MM |
| Taxes | $-3.84MM | $2.40MM | $0.09MM |
| Profit(Loss)* | $-9.52MM | $0.40MM | $-2.43MM |
| Stockholders Equity | $-11.03MM | $-13.22MM | $-18.61MM |
| Inventory | $0.77MM | $0.66MM | $0.41MM |
| Assets | $61.22MM | $64.68MM | $61.73MM |
| Operating Cash Flow | $8.92MM | $6.01MM | $5.48MM |
| Capital expenditure | $7.64MM | $2.40MM | $0.23MM |
| Investing Cash Flow | $-8.14MM | $-4.88MM | $-0.98MM |
| Financing Cash Flow | $-2.07MM | $-0.98MM | $-4.75MM |
| Earnings Per Share** | $-1.14 | $0.05 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.